Nifty

:

22620.40

Sensex

:

73730.16

50.05 (0.22%)
-609.28 (-0.82%)

Login

Nifty
Sensex

:
:

22620.40
73730.16

50.05 (0.22%)
-609.28 (-0.82%)

Supriya Lifescience Ltd.

Pharmaceuticals & Drugs

Rating :

69/99

BSE: 543434 | NSE: SUPRIYA

Watchlist

NSE BSE

409.50

26-Apr-2024

Open
High
Low
Previous Close

414.10
419.70
406.25
413.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

402558
1670.52
424.00
215.20

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,304.22
27.44
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,188.51
0.15%
4.22

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.09
10.65
5.62

EBITDA CAGR (%)

10 Years
5 Years
3 Years

24.26
14.79
-5.80

PAT CAGR (%)

10 Years
5 Years
3 Years

30.51
17.92
-10.08

P:E (Median)

8 Years
5 Years
3 Years

-
-
21.60

P:BV (Average)

8 Years
5 Years
3 Years

-
-
3.37

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
13.00

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 140.07 105.14 33.22% 140.09 112.17 24.89% 132.02 101.35 30.26% 142.27 181.27 -21.51%
Expenses 98.59 91.10 8.22% 108.34 83.61 29.58% 87.53 70.11 24.85% 87.22 106.05 -17.76%
EBITDA 41.49 14.04 195.51% 31.75 28.56 11.17% 44.49 31.25 42.37% 55.05 75.22 -26.81%
EBIDTM 29.62% 13.36% 22.66% 25.46% 33.70% 30.83% 38.69% 41.50%
Other Income 3.06 2.56 19.53% 2.47 2.61 -5.36% 2.92 2.36 23.73% 1.96 3.85 -49.09%
Interest 0.49 1.01 -51.49% 0.46 0.78 -41.03% 0.82 0.58 41.38% 0.71 1.02 -30.39%
Depreciation 3.96 2.95 34.24% 3.98 2.97 34.01% 3.95 2.89 36.68% 3.01 2.58 16.67%
PBT 40.10 12.64 217.25% 29.78 27.42 8.61% 42.64 30.14 41.47% 53.29 75.48 -29.40%
Tax 10.31 3.13 229.39% 5.89 10.56 -44.22% 14.13 4.89 188.96% 15.06 29.27 -48.55%
PAT 29.79 9.52 212.92% 23.88 16.86 41.64% 28.51 25.25 12.91% 38.23 46.21 -17.27%
PATM 21.27% 9.05% 17.05% 15.03% 21.60% 24.91% 26.87% 25.49%
EPS 3.70 1.18 213.56% 2.97 2.09 42.11% 3.54 3.14 12.74% 4.75 5.74 -17.25%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 554.45 460.94 530.05 391.22 311.64 277.84 212.91 183.50 170.66 137.87 113.06 Net Sales Growth 10.91% -13.04% 35.49% 25.54% 12.17% 30.50% 16.03% 7.52% 23.78% 21.94% Cost Of Goods Sold 211.03 180.81 195.80 128.13 138.48 146.87 135.50 122.98 107.43 88.28 72.27 Gross Profit 343.42 280.13 334.24 263.09 173.16 130.96 77.41 60.52 63.22 49.59 40.78 GP Margin 61.94% 60.77% 63.06% 67.25% 55.56% 47.14% 36.36% 32.98% 37.04% 35.97% 36.07% Total Expenditure 381.68 332.50 316.06 218.07 213.26 213.41 190.96 166.38 151.00 120.71 98.42 Power & Fuel Cost - 20.95 14.07 9.24 8.97 8.06 7.03 6.93 6.64 5.25 4.74 % Of Sales - 4.55% 2.65% 2.36% 2.88% 2.90% 3.30% 3.78% 3.89% 3.81% 4.19% Employee Cost - 55.58 49.08 32.76 25.59 18.97 16.30 12.61 10.48 9.29 7.37 % Of Sales - 12.06% 9.26% 8.37% 8.21% 6.83% 7.66% 6.87% 6.14% 6.74% 6.52% Manufacturing Exp. - 28.71 20.01 14.05 15.29 18.59 14.36 9.35 5.82 3.91 2.01 % Of Sales - 6.23% 3.78% 3.59% 4.91% 6.69% 6.74% 5.10% 3.41% 2.84% 1.78% General & Admin Exp. - 16.72 11.05 8.76 9.08 6.92 8.02 8.17 10.14 4.47 3.32 % Of Sales - 3.63% 2.08% 2.24% 2.91% 2.49% 3.77% 4.45% 5.94% 3.24% 2.94% Selling & Distn. Exp. - 24.16 22.56 23.12 13.72 11.54 9.18 2.84 3.55 3.04 2.61 % Of Sales - 5.24% 4.26% 5.91% 4.40% 4.15% 4.31% 1.55% 2.08% 2.20% 2.31% Miscellaneous Exp. - 5.57 3.49 2.02 2.12 2.45 0.57 3.50 6.93 6.47 2.61 % Of Sales - 1.21% 0.66% 0.52% 0.68% 0.88% 0.27% 1.91% 4.06% 4.69% 5.39% EBITDA 172.78 128.44 213.99 173.15 98.38 64.43 21.95 17.12 19.66 17.16 14.64 EBITDA Margin 31.16% 27.86% 40.37% 44.26% 31.57% 23.19% 10.31% 9.33% 11.52% 12.45% 12.95% Other Income 10.41 9.99 7.58 5.00 11.07 8.33 8.59 7.45 2.39 2.41 1.85 Interest 2.48 3.13 4.20 4.08 6.85 10.22 10.75 11.76 10.04 6.92 6.05 Depreciation 14.90 11.81 10.12 6.76 6.38 5.43 5.33 4.75 3.95 2.49 1.94 PBT 165.81 123.49 207.24 167.31 96.23 57.10 14.46 8.06 8.06 10.16 8.51 Tax 45.39 33.63 55.44 43.72 22.82 17.68 5.74 2.40 2.37 1.95 2.24 Tax Rate 27.37% 27.23% 26.75% 26.13% 23.71% 30.96% 39.70% 29.78% 29.40% 19.19% 26.32% PAT 120.41 89.86 151.81 123.59 73.40 39.42 8.73 5.66 5.69 8.21 6.27 PAT before Minority Interest 120.41 89.86 151.81 123.59 73.40 39.42 8.73 5.66 5.69 8.21 6.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 21.72% 19.49% 28.64% 31.59% 23.55% 14.19% 4.10% 3.08% 3.33% 5.95% 5.55% PAT Growth 23.07% -40.81% 22.83% 68.38% 86.20% 351.55% 54.24% -0.53% -30.69% 30.94% EPS 14.96 11.16 18.86 15.35 9.12 4.90 1.08 0.70 0.71 1.02 0.78

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 699.46 615.69 268.58 149.19 93.79 54.66 45.89 41.72 37.38 30.43 Share Capital 16.10 16.10 14.64 14.64 14.64 14.64 14.64 14.64 4.88 4.88 Total Reserves 683.36 599.59 253.95 134.56 79.15 40.02 31.25 26.04 32.51 25.55 Non-Current Liabilities 25.04 19.38 30.86 31.85 24.36 44.86 51.30 39.21 23.35 17.22 Secured Loans 0.00 0.00 0.00 2.39 8.14 35.33 43.78 30.57 16.94 13.38 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 1.62 3.84 2.73 0.87 Long Term Provisions 5.88 2.93 1.30 1.03 0.69 0.58 0.00 0.00 0.00 0.00 Current Liabilities 95.78 99.70 146.02 155.39 134.91 145.88 144.15 150.26 114.88 82.60 Trade Payables 64.23 48.97 51.02 49.39 44.13 41.75 40.69 49.79 29.85 30.89 Other Current Liabilities 9.51 22.61 11.48 25.67 8.24 14.82 5.94 4.21 3.99 2.45 Short Term Borrowings 16.63 21.30 67.41 76.68 77.21 85.74 94.67 94.69 79.08 47.35 Short Term Provisions 5.42 6.82 16.11 3.64 5.33 3.56 2.84 1.57 1.96 1.91 Total Liabilities 820.28 734.77 445.46 336.43 253.06 245.40 241.34 231.19 175.61 130.25 Net Block 261.54 189.77 100.04 97.99 84.68 91.01 88.78 75.45 61.17 45.23 Gross Block 306.49 222.92 123.06 114.08 94.56 95.58 97.53 89.25 71.01 52.57 Accumulated Depreciation 44.95 33.14 23.03 16.08 9.88 4.57 8.75 13.80 9.84 7.34 Non Current Assets 355.39 237.22 180.00 138.44 120.39 125.82 126.31 102.29 72.55 51.78 Capital Work in Progress 67.63 43.41 78.79 40.21 35.35 34.38 35.58 25.18 10.96 5.45 Non Current Investment 25.30 0.05 0.05 0.05 0.05 0.12 0.10 0.10 0.10 0.09 Long Term Loans & Adv. 0.93 3.98 1.13 0.18 0.30 0.32 1.84 1.55 0.33 1.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 464.89 497.54 265.46 197.99 132.66 119.57 115.04 128.91 103.06 78.48 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 115.77 92.31 72.48 49.46 30.73 31.70 38.22 53.04 39.09 30.17 Sundry Debtors 84.67 115.18 73.50 52.49 59.95 53.40 49.61 42.34 35.36 27.84 Cash & Bank 157.58 227.91 89.28 1.54 1.73 2.73 5.58 7.09 5.06 4.31 Other Current Assets 106.87 13.28 4.01 1.11 40.25 31.74 21.63 26.44 23.55 16.16 Short Term Loans & Adv. 89.62 48.86 26.19 93.40 39.93 31.11 20.34 25.80 22.54 15.60 Net Current Assets 369.11 397.84 119.44 42.60 -2.25 -26.30 -29.11 -21.35 -11.82 -4.13 Total Assets 820.28 734.76 445.46 336.43 253.05 245.39 241.35 231.20 175.61 130.26

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 66.19 48.80 75.89 116.06 48.88 27.75 27.30 13.50 -6.25 0.00 PBT 123.49 207.24 167.31 96.23 57.10 14.46 8.06 8.06 10.16 0.00 Adjustment 7.20 6.87 5.39 10.24 12.67 15.78 16.47 13.30 8.84 0.00 Changes in Working Capital -35.64 -104.35 -66.82 36.60 -6.80 0.80 2.87 -6.74 -24.61 0.00 Cash after chg. in Working capital 95.04 109.76 105.88 143.07 62.98 31.04 27.40 14.62 -5.61 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -28.86 -60.96 -29.99 -27.00 -14.09 -3.29 -0.10 -0.46 -0.24 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.66 -0.40 0.00 Cash From Investing Activity -133.14 -59.82 -46.80 -24.52 4.83 -4.71 -26.61 -32.83 -23.22 0.00 Net Fixed Assets -107.79 -64.48 -47.56 -24.38 0.05 3.15 -18.68 -32.46 -23.95 -13.75 Net Investments -25.25 0.00 0.00 0.00 0.07 -0.02 0.00 0.00 -0.01 -0.06 Others -0.10 4.66 0.76 -0.14 4.71 -7.84 -7.93 -0.37 0.74 13.81 Cash from Financing Activity -3.37 149.65 -14.52 -29.23 -49.92 -20.01 -2.21 21.36 30.22 0.00 Net Cash Inflow / Outflow -70.32 138.63 14.57 62.31 3.79 3.03 -1.51 2.03 0.75 0.00 Opening Cash & Equivalents 227.91 89.28 74.70 12.40 8.61 5.58 7.09 5.06 4.31 0.00 Closing Cash & Equivalent 157.58 227.91 89.28 74.70 12.40 8.61 5.58 7.09 5.06 0.00

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 86.91 76.50 36.70 101.93 64.08 37.34 27.56 23.82 64.19 49.40 ROA 11.56% 25.73% 31.61% 24.90% 15.82% 4.65% 2.40% 2.80% 5.37% 5.42% ROE 13.66% 34.34% 59.17% 60.42% 53.11% 22.16% 15.05% 17.20% 29.61% 29.57% ROCE 18.72% 43.34% 60.12% 49.67% 36.52% 18.63% 11.48% 12.27% 15.83% 19.43% Fixed Asset Turnover 1.95 3.40 3.63 3.45 3.38 3.23 2.09 2.32 2.43 2.48 Receivable days 70.62 58.51 53.35 57.07 64.39 61.89 86.01 76.12 76.86 69.36 Inventory Days 73.53 51.10 51.64 40.70 35.46 47.13 85.36 90.25 84.22 92.00 Payable days 114.26 93.20 143.03 123.24 74.29 68.83 106.73 95.88 95.94 106.96 Cash Conversion Cycle 29.89 16.41 -38.04 -25.47 25.56 40.19 64.64 70.49 65.15 54.40 Total Debt/Equity 0.02 0.03 0.26 0.55 0.96 2.39 3.47 3.70 3.15 2.56 Interest Cover 40.43 50.37 42.01 15.05 6.59 2.34 1.69 1.80 2.47 2.41

Top Investors:

aditya birla sun life insurance company limited

cohesion mk best ideas sub-trust

hornbill orchid india fund

Annual Reports:

News Update:

Supriya Lifescience - Quarterly Results
7th Feb 2024, 17:44 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback